AAAAAA
Results:
1-19
|
Results: 19
Authors:
SIMPSON DR
NEVILL TJ
SHEPHERD JD
FUNG HC
HORSMAN DE
NANTEL SH
VICKARS LM
SUTHERLAND HJ
TOZE CL
HOGGE DE
KLINGEMANN HG
NAIMAN SC
BARNETT MJ
Citation: Dr. Simpson et al., HIGH-INCIDENCE OF EXTRAMEDULLARY RELAPSE OF AML AFTER BUSULFAN CYCLOPHOSPHAMIDE CONDITIONING AND ALLOGENEIC STEM-CELL TRANSPLANTATION/, Bone marrow transplantation, 22(3), 1998, pp. 259-264
Authors:
SCHULTZ KR
NEVILL TJ
TOZE CL
CORR T
CURRIE C
STRONG DK
KEOWN PA
Citation: Kr. Schultz et al., THE PHARMACOKINETICS OF ORAL CYCLOSPORINE-A (NEORAL) DURING THE FIRSTMONTH AFTER BONE-MARROW TRANSPLANTATION, Transplantation proceedings, 30(5), 1998, pp. 1668-1670
Authors:
NEVILL TJ
FUNG HC
SHEPHERD JD
HORSMAN DE
NANTEL SH
KLINGEMANN HG
FORREST DL
TOZE CL
SUTHERLAND HJ
HOGGE DE
NAIMAN SC
LE A
BROCKINGTON DA
BARNETT MJ
Citation: Tj. Nevill et al., CYTOGENETIC ABNORMALITIES IN PRIMARY MYELODYSPLASTIC SYNDROME ARE HIGHLY PREDICTIVE OF OUTCOME AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 92(6), 1998, pp. 1910-1917
NORMAL CD5(-LYMPHOCYTES ARE POOR STIMULATORS IN THE AUTOLOGOUS MIXED LYMPHOCYTE-REACTION (AMLR)() B)
Authors:
FERNANDEZ LA
CHENG R
SADEK I
NEVILL TJ
MACSWEEN JM
Citation: La. Fernandez et al., NORMAL CD5(-LYMPHOCYTES ARE POOR STIMULATORS IN THE AUTOLOGOUS MIXED LYMPHOCYTE-REACTION (AMLR)() B), Clinical and experimental immunology, 108(3), 1997, pp. 557-561
Authors:
NEVILL TJ
SHEPHERD JD
NANTEL SH
TOZE CL
HOGGE DE
SUTHERLAND HJ
BARNETT MJ
Citation: Tj. Nevill et al., STEM-CELL TRANSPLANT-RELATED MORTALITY (TRM) 1985-1996 - THE VANCOUVER EXPERIENCE, Blood, 90(10), 1997, pp. 4426-4426
Authors:
SCHULTZ KR
NEVILL TJ
TOZE CL
CORR T
CURRIE C
STRONG DK
KEOWN PA
Citation: Kr. Schultz et al., THE PHARMACOKINETICS OF ORAL CYCLOSPORINE-A (NEORAL) DURING THE FIRSTMONTH AFTER BONE-MARROW TRANSPLANTATION (BMT), Blood, 90(10), 1997, pp. 4434-4434
Authors:
TOZE CL
SHEPHERD JD
NANTEL SH
KLINGEMANN HG
SUTHERLAND HJ
NEVILL TJ
HOGGE DE
GASCOYNE RD
CONNORS JM
BARNETT MJ
Citation: Cl. Toze et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR LOW-GRADE LYMPHOMA (LGL) AND CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), Blood, 90(10), 1997, pp. 4513-4513
Authors:
WATSON AL
BARNETT MJ
NANTEL SH
TOZE CL
NEVILL TJ
HOGGE DE
KLINGEMANN HG
SUTHERLAND HJ
CONNORS JM
GASCOYNE RD
SCHULTZ KR
DAVIS JH
NITTA JY
SHEPHERD JD
Citation: Al. Watson et al., TREATMENT OF PROGRESSIVE INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA WITH INTENSIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 4515-4515
Authors:
FORREST DL
NEVILL TJ
HORSMAN DE
SHEPHERD JD
NANTEL SH
SUTHERLAND HJ
TOZE CL
HOGGE DE
NITTA JY
BARNETT MJ
Citation: Dl. Forrest et al., HIGH-DOSE CHEMO RADIOTHERAPY (HDCT) AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) FOR ADULT ACUTE-LEUKEMIA WITH 11Q23 CHROMOSOMAL-ABNORMALITIES/, Blood, 90(10), 1997, pp. 1671-1671
Authors:
FORREST DL
NEVILL TJ
CONNORS JM
SHEPHERD JD
NANTEL SH
SUTHERLAND HJ
HOGGE DE
TOZE CL
BARNETT MJ
Citation: Dl. Forrest et al., LONG-TERM FOLLOW-UP OF 100 PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY(HDCT) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR HODGKINS-DISEASE (HD), Blood, 90(10), 1997, pp. 2636-2636
Authors:
NEVILL TJ
FERNANDEZ LA
ANDERSON DR
LANGLEY GR
ROBINSON KS
HAYNE OA
ING VW
Citation: Tj. Nevill et al., ALLOGENEIC STEM-CELL TRANSPLANTATION (SCT) FOR HEMATOLOGIC MALIGNANCIES IN PATIENTS (PTS) AGED 45-55 YEARS (YRS), Blood, 88(10), 1996, pp. 3832-3832
Authors:
NEVILL TJ
ROBINSON KS
ING VW
HAYNE OA
ANDERSON DR
FERNANDEZ LA
LANGLEY GR
Citation: Tj. Nevill et al., EARLY ALLOGENEIC STEM-CELL TRANSPLANTATION (SCT) FOR CHEMOSENSITIVE MULTIPLE-MYELOMA (MM), Blood, 88(10), 1996, pp. 3833-3833
Authors:
PHILLIPS GL
NEVILL TJ
SPINELLI JJ
NANTEL SH
KLINGEMANN HG
BARNETT MJ
SHEPHERD JD
CHAN KW
MEHARCHAND JM
SUTHERLAND HJ
REECE DE
MESSNER HA
Citation: Gl. Phillips et al., PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING UNRELATED DONOR BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(2), 1995, pp. 213-219
Authors:
GALAL A
FOYLE A
NEVILL TJ
ZAYED E
Citation: A. Galal et al., TREATMENT OF A PATIENT WITH AGGRESSIVE NATURAL-KILLER (NK) CELL LEUKEMIA WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 3771-3771
Authors:
WHITE DJ
NEVILL TJ
MCALISTER VC
Citation: Dj. White et al., SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION (OLT) FOR FULMINANT HEPATIC-FAILURE AND SEVERE APLASTIC-ANEMIA (SAA) DUE TO NON-A-HEPATITIS, NON-B-HEPATITIS, NON-C-HEPATITIS, Blood, 86(10), 1995, pp. 3882-3882
Authors:
NEVILL TJ
HAYNE OA
ANDERSON DR
FERNANDEZ LA
ING VK
ROBINSON KS
LANGLEY GR
Citation: Tj. Nevill et al., EVALUATION OF BUSULFAN (BU)-BASED CONDITIONING REGIMENS PRIOR TO BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS (PTS) WITH LYMPHOID MALIGNANCIES, Blood, 84(10), 1994, pp. 10000716-10000716
Authors:
BARNETT MJ
COPPIN CML
MURRAY N
NEVILL TJ
REECE DE
KLINGEMANN HG
SHEPHERD JD
NANTEL SH
SUTHERLAND HJ
PHILLIPS GL
Citation: Mj. Barnett et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FORPATIENTS WITH POOR-PROGNOSIS NONSEMINOMATOUS GERM-CELL TUMORS, British Journal of Cancer, 68(3), 1993, pp. 594-598
Authors:
NEVILL TJ
WARNER MN
ANDERSON DR
FERNANDEZ LA
HAYNE OA
ING VW
LANGLEY GR
PYESMANY AF
ROBINSON KS
ZAYED E
Citation: Tj. Nevill et al., A SINGLE INSTITUTIONS 10-YEAR EXPERIENCE WITH THE ACID HEMOLYSIS TEST(AHT) - CHARACTERIZATION OF A PATIENT SUBGROUP WITH MYELODYSPLASTIC SYNDROME AND A POSITIVE AHT, Blood, 82(10), 1993, pp. 10000096-10000096
Authors:
NEVILL TJ
ZAYED E
HAYNE OA
LANGLEY GR
ING VW
ANDERSON DR
FERNANDEZ LA
ROBINSON KS
GREER WL
Citation: Tj. Nevill et al., INSENSITIVITY OF VARIABLE NUMBER OF TANDEM REPEATS (VNTR) ANALYSIS ASA MARKER OF MINIMAL RESIDUAL DISEASE (MRD) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) - A REPORT OF DISCREPANT DNA ANALYSES, Blood, 82(10), 1993, pp. 10000638-10000638
Risultati:
1-19
|